Phentermine cardiovascular safety II: response to Rothman Hendricks Int J Cardiol. 2009 epub Mar 19

Int J Cardiol. 2010 Nov 19;145(2):407-408. doi: 10.1016/j.ijcard.2010.04.044. Epub 2010 May 14.

Authors

Chaim Yosefy¹, Ronen Beeri²

Affiliations

¹ Non Invasive Cardiology Unit, Barzilai Medical Center Campus, Ben-Gurion University, Ashkelon, Israel. Electronic address: yosefy@barzi.health.gov.il.
² Cardiovascular Research Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Electronic address: rbeeri@partners.org.

PMID: 20471119
DOI: 10.1016/j.ijcard.2010.04.044

No abstract available

Publication types

Comment
Letter

MeSH terms

Heart Valve Diseases / chemically induced*
Heart Valve Diseases / pathology
Heart Valve Diseases / prevention & control
Humans
Mitral Valve / pathology
Phentermine / adverse effects*

Substances

Phentermine